Year: 2025
Type: article
Abstract: INTRODUCTION By integrating genetic and clinical risk factors into genomic‐informed dementia risk reports, healthcare providers can offer patients detailed risk profiles to facilitate understanding of individual risk and support the implementation of personalized strategies for promoting brain health. METHODS We constructed an additive score comprising the modified Cardiovascular Risk Factors, Aging, and Incidence of Dementia Risk Score (mCAIDE), family history of dementia , apolipoprotein E (APOE) genotype, and an Alzheimer's disease (AD) polygenic risk score in National Alzheimer's Coordinating Center (NACC) and Alzheimer's Disease Neuroimaging Iniative (ADNI), and assessed its association with progression to all‐cause dementia. RESULTS A total of 81% of participants had at least one high‐risk indicator for dementia, with each additional risk indicator linked to a 34% increase in the hazard of dementia onset. DISCUSSION We found that most participants in memory and aging clinics had at least one high‐risk indicator for dementia. Furthermore, we observed a dose‐response relationship where a greater number of risk indicators was associated with an increased risk of incident dementia. Highlights Compiled genomic‐informed dementia risk report of genetic and clinical risk factors. Most memory clinic patients have at least one high‐risk indicator for dementia. A higher risk indicator burden is associated with a greater dementia risk.
Source: Alzheimer s & Dementia
DOI: 10.1002/alz.70826
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,200
Funders: U.S. Department of Health and Human Services, Wellcome Trust, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, National Institutes of Health, National Institute on Aging, National Heart, Lung, and Blood Institute, National Human Genome Research Institute, National Institute of Neurological Disorders and Stroke
Awards: G1002540797, G100543330, G1007389970, G1024368718, G102769902, G104586243, G1048051091, G1052397333, G1069732457, G1135917780, Genomic approach to identification of microglial networks involved in Alzheimer disease risk, G117713310, G1181549146, G1194337659, G120189231, G1220223050, G1243299691, G1269895679, CORONARY HEART DISEASE AND STROKE, CORONARY HEART DISEASE &STROKE IN PEOPLE AGED 65-84, G1307745024, G1309605592, Indiana Alzheimer Disease Center, G1353455142, G1355015391, G1379949353, Genetic Studies of Dementia in the Amish, VCID and Stroke in a Bi-racial National Cohort, G1458362881, G1479745523, G1527150935, G1572572531, G1576357080, G1593128567, G1602390028, G1609525565, CORONARY HEART DISEASE AND STROKE, G1632916191, G1648032802, G1691174148, G173303992, G1753564228, G1827328465, G1843559518, G1859882300, G1871439151, Genetic Studies in Neurological Disorders, G1941623656, G1946062844, Integrative translational discovery of vascular risk factors in aging and dementia, Large Scale Sequencing and Analysis of Genomes, G2037330952, G2167172591, G2190936067, G2194386449, G2195207551, G2234397790, CORONARY HEART DISEASE &STROKE IN PEOPLE AGED 65-84, G2334183842, G2360966051, G2363791470, G2391884931, Genetic Drivers of Resilience to Alzheimer's Disease, G2434699210, G247538147, G253265979, G2555427744, G2622865600, CORONARY HEART DISEASE &STROKE IN THE ELDERLY, G2675915175, G2681560673, G2682171662, G272783259, G2742075923, G2745100336, G278200998, G2818629771, G2908616768, G2957681590, G2984989008, G302197427, G3045517347, G3083277455, G3114902838, G313278407, G3220743633, G332781187, G3342163884, Genetic Modifiers of Alzheimer Disease in PSEN1 Mutation Carriers in Puerto Rico, G3405256882, G3410686264, USING QUANTITATIVE TRAITS TO IDENTIFY NOVEL GENES FOR ALZHEIMERS DISEASE AND OTHER COMPLEX TRAITS, G343469054, G3462919067, G348743638, G3487525919, CHS research resources for the cardiovascular health of older adults, G36433118, G3677674694, G3703765782, Alzheimer Disease Genetic Architecture in African Americans, G3743240706, ADSP Follow-up in Multi-Ethnic Cohorts via Endophenotypes, Omics & Model Systems, G3839646794, G3952091757, Genomic Convergence in Alzheimer Disease, G3972194382, G3976056932, CENTRAL BLOOD ANALYSIS LABORATORY FOR CHS, Predictors of Alheimers Disease in Mild Cognitive Impairment, G4000272535, G4122177659, G4132040473, G413369726, G415047313, G415358893, G4186766937, G418866124, G4202057321, Nevada Exploratory Alzheimer's Disease Research Center (NVEADRC), G4271311981, G4290615481, G4365567135, G4427631003, G4429312988, G4451993153, Replication and Extension of ADSP Discoveries in African-Americans, The Human Genome Sequencing Center, G4559892875, G457330776, Alzheimer's Disease and Gene Discovery on Chromosome 9, G461742567, ARIC Neurocognitive Study (ARIC-NCS) Renewal UNC 4 of 5, G4702044304, G4706374277, G4728428359, G4740807435, Risk Factors, Pathology, and Clinical Expressions of AD, UAB Alzheimer's Disease Research Center, G494123624, G504619356, G5083024019, G5105220586, G5130436076, Whole Genome Sequencing in Ethnically Diverse Cohorts for the ADSP Follow-Up Study (FUS), Alzheimer's Disease Genetics Consortium, G5285701454, G5320812618, Genomic and Metabolomic Data Integration in a Longitudinal Cohort at Risk for Alzheimer's Disease, G5364873420, G5370164845, G5417114274, G5479317095, G5550345989, Genetic Epidemiology of Cerebrovascular Factors in Alzheimer's Disease, G5640525220, G5652732059, MRI, Cognitive, Genetic and Biomarker Precursors of AD & Dementia in Young Adults, G5667409946, G567847597, G5681130674, Alzheimer's Disease Neuroimaging Initiative, Progression of Dementia: A Population Study, G581887176, G583528397, Additional Sequencing Cohorts for the Alzheimer's Disease Sequencing Project, CHS Events Follow-up Study, Epidemiology of Familial Late-Onset Alzheimer's Disease, G6141462147, G6226795708, IDENTIFYING RARE VARIANTS THAT INCREASE RISK FOR ALZHEIMER'S DISEASE, The Framingham Heart Study, Genetic Studies of Alzheimer Disease in Koreans, G6548750934, Protective Genetic Variants for Alzheimer Disease in the Amish, CHS-Transition Phase, G6745504663, ARIC Neurocognitive Study (ARIC-NCS) Renewal 2 of 5, ARIC Neurocognitive Study (ARIC-NCS), New Mexico Alzheimer's Disease Research Center, G6978868085, Genome wide association study of gene expression levels in Alzheimer's disease, G703150377, G7176672723, G7270237958, G740377980, G745744428, Vanderbilt Alzheimer's Disease Research Center, Genomic Characterization of Alzheimer's Disease Risk in the Puerto Rican Population, An Integrated Genomic Approach to Alzheimer Disease, Genetic Epidemiological Studies of Alzheimer Disease, G816726602, G824429988, G828200374, G835908364, LGP/Longenity, Identification and characterization of AD risk networks using multi-dimensional "omics" data, Genetic Epidemiology of Alzheimer's Disease in Hispanics, G9000156616, G9000198119, Boston University Alzheimer's Disease Research Center, Yale Alzheimer Disease Research Center, UCSD Shiley-Marcos Alzheimer's Disease Research Center P30, Genomic and Metabolomic Data Integration in a Longitudinal Cohort at Risk for Alzheimer's Disease, Adult Changes in Thought (ACT) Research Program, Joint Estimate Diffusion Imaging (JEDI) for improved Tissue Characterization and Neural Connectivity in Aging and Alzheimer's Disease, Alzheimer's Disease Sequencing Project Phenotype Harmonization Consortium, University of Kansas Alzheimer's Disease Research Center (KU ADRC), Wisconsin Registry for Alzheimer's Prevention, Alzheimer Disease Research Center, Alzheimer's Disease Research Center, Alzheimer's Disease Neuroimaging Initiative (ADNI4), The Mexican Health Aging Study (MHAS), Johns Hopkins Alzheimer's Disease Research Center, Stanford Alzheimer's Disease Research Center, University of Washington Alzheimer's Disease Research Center, Wisconsin Alzheimer's Disease Research Center, Alzheimer's Disease Research Centers, University of Kentucky Alzheimer's Disease Research Center, Penn Alzheimer's Disease Research Center (ADRC), Antecedent Biomarkers for Alzheimer Disease: The Adult Children Study, National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD), Massachusetts Alzheimer's Disease Research Center (MADRC), Goizueta Alzheimer's Disease Research Center, Center for Alzheimer's and Related Dementias (CARD): Harmonized Data-Derived Resources for the Alzheimer's Disease and Related Dementias Community, The Alzheimer's Disease Research Center at the University of California, Irvine, Ultrascale Machine Learning to Empower Discovery in Alzheimers Disease Biobanks, G939786002, G950304953, Mayo Alzheimer's Disease Research Center, Indianapolis-Ibadan Dementia Project, G983864884
OpenAlex ID: W4416461994